Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.493NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.351.2 (Beta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.640.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.352NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.251NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCJNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FT.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.332NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JB.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.141NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.591NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.468NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.131 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.586NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.366NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.380NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.148NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.382NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.356NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.376NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.607NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.163NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.337NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.602NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.289NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDHNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.66NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.21.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used